Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65 [see Clinical Studies (14)].
- generic_name
- methylphenidate hydrochloride
- product_names
- Methylphenidate Hydrochloride
- ndc
- 62037-725, 62037-725-01, 62037-734, 62037-734-01, 62037-726, 62037-726-01, 62037-727, 62037-727-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en